314930 — Biodyne Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Biodyne Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-2,026	-4,454	-10,857	5,611	-992
Depreciation
Amortisation
Non-Cash Items	1,680	2,704	8,930	1,239	-1,034
Unusual Items
Other Non-Cash Items
Changes in Working Capital	3,420	650	78.2	-5,822	765
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	4,203	116	-505	2,586	405
Capital Expenditures	-11,056	-796	-866	-1,562	-670
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,465	462	-14,499	205	-1,000
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-12,520	-334	-15,364	-1,357	-1,670
Financing Cash Flow Items	-3.4	—	-1,865	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	7,585	2,806	22,109	-10.2	193
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-759	2,325	6,471	1,280	-1,008